Anti-HER2 ADCs Antibody-drug conjugates (ADCs) are a rapidly developing therapeutic approach in cancer treatment that has shown remarkable activity in breast cancer
It is too cloudy to give a firm recommendation for or against L-carnitine supplementation
*GLP-1 side effects (nausea, vomiting) are common but typically manageable with proper dosing titration
(PubMed) May JM, Mendiratta S, Hill KE, Burk RF
N., Wharton, S., Connery, L., Alves, B., & Garvey, W
It does so by activating genes that are associated with repair and regeneration while suppressing those linked to inflammation and aging